Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Nurix Therapeutics, Inc. (NRIX) had Book Value Per Share of $5.29 for the most recently reported fiscal quarter, ending 2025-11-30.
| Income Statement Financials | |
$13.58M |
|
$-78.22M |
|
-- |
|
$13.58M |
|
$96.67M |
|
$-83.09M |
|
$4.87M |
|
$-78.22M |
|
$-78.22M |
|
$-78.22M |
|
$-78.22M |
|
$-78.22M |
|
$-78.22M |
|
$-83.09M |
|
$-88.79M |
|
86.67M |
|
86.67M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$606.82M |
|
$22.49M |
|
$81.32M |
|
$688.13M |
|
$86.47M |
|
-- |
|
$62.92M |
|
$149.39M |
|
$538.75M |
|
$538.75M |
|
$538.75M |
|
101.81M |
|
| Cash Flow Statement Financials | |
$-249.47M |
|
$147.85M |
|
$238.64M |
|
$110.90M |
|
$247.93M |
|
$137.03M |
|
$37.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-612.03% |
|
-612.03% |
|
-- |
|
-576.13% |
|
-576.13% |
|
$-263.47M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-14.52% |
|
-14.52% |
|
-11.37% |
|
-14.52% |
|
|
Book Value Per Share |
$5.29 |
$-3.04 |
|
$-2.88 |
|